ClinicalTrials.Veeva

Menu

AI in GIM Diagnosis

K

King Chulalongkorn Memorial Hospital

Status

Unknown

Conditions

GIM Diagnosis
Artificial Intellegence

Treatments

Diagnostic Test: Artificial intelligence

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study will use artificial intelligence (AI) for diagnosing gastric intestinal metaplasia.

Full description

The patients with previously diagnose gastric intestinal metaplasia (GIM) and have the surveillance gastroscopy will be enrolled. The routine surveillance program will be performed additional to taking photo at both GIM and normal mucosa at least 5 pictures in each. Biopsy will be done to confirm the diagnosis of GIM and normal mucosa. All pictures will be inserted to AI algorithm based on the convolutional neural network (CNN). Then, the AI program will be validated in daily endoscopy compared with pathology. Accuracy, sensitivity and specificity can be calculated by 2x2 table.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • More than 18 years of age
  • Able to sign a consent form

Exclusion criteria

  • History of gastric surgery
  • Coagulopathy
  • Pregnancy/Breast feeding

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

120 participants in 1 patient group

GIM patient
Experimental group
Description:
The patients with GIM will be assessed at both GIM and normal mucosa during endoscopy.
Treatment:
Diagnostic Test: Artificial intelligence

Trial contacts and locations

1

Loading...

Central trial contact

Rapat Pittayanon, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems